Active Ingredient(s):Neostigmine Methylsulfate FDA Approved: * May 31, 2013 Pharm Company: *ECLAT PHARMS LLC Category:Myasthenic Syndrome
Neostigmine, sold under the brand name Bloxiverz, among others, is a medication used to treat myasthenia gravis, Ogilvie syndrome, and urinary retention without the presence of a blockage.[2][3] It is also used in anaesthesia to end the effects of non-depolarising neuromuscular blocking medication.[2] It is given by injection either into a vein, muscle, or under the skin.[2] After injection effects are generally greatest within 3...
[wikipedia]
* May have multiple approval dates, manufacturers, or labelers.
